Hôpital Louis Pradel

Lyon 69000

0 studies enrolling now · 5 studies all time

What they study most

Coronary Artery Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Pulmonary Embolism, Pulmonary Hypertension

Studies at this site

• The PEERLESS II Study — Running, not enrolling
• An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension — Completed
• FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?) — Completed
• Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis — Completed